Age and sex dependent genetic effects of neuropeptide Y promoter polymorphism on susceptibility to ischemic stroke in Koreans

Clinica Chimica Acta

Volumn 411, Issue 17-18, 2010, Pages 1243-1247

  Kim, No S ^a   Ko, Mi M ^a   Cha, Min H ^a   Oh, Se Mi ^a   Bang, Ok S ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Association; Ischemic stroke; NPY; Polymorphism; Risk factor

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NEUROPEPTIDE Y;

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; BODY MASS; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; KOREA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; STROKE PATIENT; TREND STUDY; AGE; CEREBROVASCULAR ACCIDENT; ENZYME IMMUNOASSAY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

AGE FACTORS; AGED; BRAIN ISCHEMIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; KOREA; MALE; MIDDLE AGED; NEUROPEPTIDE Y; PROMOTER REGIONS, GENETIC; SEX FACTORS; STROKE;

EID: 77954144992     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.04.026     Document Type: Article

References (37)

1. Wahlestedt C., Reis D.J. Neuropeptide Y-related peptides and their receptors-are the receptors potential therapeutic drug targets?. Annu Rev Pharmacol Toxicol 1993, 33:309-352.
2. Igwe J.C., Jiang X., Paic F., et al. Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity. J Cell Biochem 2009, 108:621-630.
3. Kolsch H., Lutjohann D., Jessen F., et al. Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer's disease. J Neural Transm 2006, 113:231-238.
4. Decressac M., Prestoz L., Veran J., Cantereau A., Jaber M., Gaillard A. Neuropeptide Y stimulates proliferation, migration and differentiation of neural precursors from the subventricular zone in adult mice. Neurobiol Dis 2009, 34:441-449.
5. Balasubramaniam A., Joshi R., Su C., Friend L.A., James J.H. Neuropeptide Y (NPY) Y2 receptor-selective agonist inhibits food intake and promotes fat metabolism in mice: combined anorectic effects of Y2 and Y4 receptor-selective agonists. Peptides 2007, 28:235-240.
6. Kuo L.E., Abe K., Zukowska Z. Stress, NPY and vascular remodeling: Implications for stress-related diseases. Peptides 2007, 28:435-440.
7. Lee E.W., Michalkiewicz M., Kitlinska J., et al. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 2003, 111:1853-1862.
8. Karvonen M.K., Valkonen V.P., Lakka T.A., et al. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men. Atherosclerosis 2001, 159:145-151.
9. Karvonen M.K., Pesonen U., Koulu M., et al. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med 1998, 4:1434-1437.
10. Kaipio K., Kallio J., Pesonen U. The effect of endogenous preproneuropeptide Y leucine 7 to proline 7 polymorphism on growth and apoptosis in primary cultured HUVECs. Biol Chem 2009, 390:899-905.
11. Kaipio K., Vahlberg T., Suominen M., Pesonen U. The role of non-synonymous NPY gene polymorphism in the nitric oxide production in HUVECs. Biochem Biophys Res Commun 2009, 381:587-591.
12. Kim N.S., Oh S.M., Ko M.M., Cha M.H., Kang B.K., Bang O.S. Association of the C-399T promoter polymorphism of neuropeptide Y with susceptibility to ischemic stroke. Clin Biochem 2009, 42:1699-1704.
13. Lee C., Kong M. An interactive association of common sequence variants in the neuropeptide Y gene with susceptibility to ischemic stroke. Stroke 2007, 38:2663-2669.
14. Yu J.T., Yu N.N., Gao S.S., et al. Neuropeptide Y polymorphisms and ischemic stroke in Chinese population. Clin Chim Acta 2010, 411:242-245.
15. Gretarsdottir S., Thorleifsson G., Reynisdottir S.T., et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 2003, 35:131-138.
16. Helgadottir A., Manolescu A., Thorleifsson G., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004, 36:233-239.
17. Lohmussaar E., Gschwendtner A., Mueller J.C., et al. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 2005, 36:731-736.
18. Zhang W.L., Yang X.M., Shi J., Sun K., Hui R.T. Polymorphism of SG13S114T/A in the ALOX5AP gene and the risk for stroke in a large Chinese cohort. Yi Chuan Xue Bao 2006, 33:678-684.
19. Yamada Y., Kato K., Oguri M., et al. Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome. Int J Mol Med 2008, 21:801-808.
20. Kaushal R., Pal P., Alwell K., et al. Association of ALOX5AP with ischemic stroke: a population-based case-control study. Hum Genet 2007, 121:601-607.
21. Matsushita T., Kubo M., Yonemoto K., et al. Lack of association between variations of PDE4D and ischemic stroke in the Japanese population. Stroke 2009, 40:1245-1251.
22. Kim M.K., Kim J.T., Choi S.M., Lee S.H., Park M.S., Cho K.H. Phosphodiesterase 4D gene and risk of noncardiogenic ischemic stroke in a Korean population. J Korean Med Sci 2009, 24:307-310.
23. Kubo M., Hata J., Ninomiya T., et al. A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet 2007, 39:212-217.
24. Cheng H., Wang F., Ding X., Ding H., Song X. Association of PRKCH gene with lacunar infarction in a local Chinese Han population. Neurosci Lett 2009, 464:146-149.
25. Pesonen U. NPY L7P polymorphism and metabolic diseases. Regul Pept 2008, 149:51-55.
26. Erkkila A.T., Lindi V., Lehto S., Laakso M., Uusitupa M.I. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease. Mol Genet Metab 2002, 75:260-264.
27. Salminen M., Lehtimaki T., Fan Y.M., Vahlberg T., Kivela S.L. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD. Public Health Nutr 2008, 11:1156-1162.
28. Ilveskoski E., Viiri L.E., Mikkelsson J., Porsti I., Lehtimaki T., Karhunen P.J. Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: the Helsinki Sudden Death Study. Atherosclerosis 2008, 199:445-450.
29. Wallerstedt S.M., Skrtic S., Eriksson A.L., Ohlsson C., Hedner T. Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population. J Hypertens 2004, 22:1277-1281.
30. Helbecque N., Codron V., Cottel D., Amouyel P. An age effect on the association of common variants of ACE with Alzheimer's disease. Neurosci Lett 2009, 461:181-184.
31. Ide A., Kawasaki E., Abiru N., et al. Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset. Hum Immunol 2002, 63:690-695.
32. Bao X., Mills P.J., Rana B.K., et al. Interactive effects of common beta2-adrenoceptor haplotypes and age on susceptibility to hypertension and receptor function. Hypertension 2005, 46:301-307.
33. Tambs K., Eaves L.J., Moum T., et al. Age-specific genetic effects for blood pressure. Hypertension 1993, 22:789-795.
34. Lopez-Castroman J., Vaquero-Lorenzo C., Perez-Rodriguez M.M., et al. Gender effect on association between DRD2 polymorphism and substance dependence in a Spanish sample. Drug Alcohol Depend 2009, 101:210-212.
35. Brandstatter A., Lamina C., Kiechl S., et al. Sex and age interaction with genetic association of atherogenic uric acid concentrations. Atherosclerosis 2009, doi:10.1016/j.atherosclerosis2009.12.013.
36. Ainslie D.A., Morris M.J., Wittert G., Turnbull H., Proietto J., Thorburn A.W. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obes Relat Metab Disord 2001, 25:1680-1688.
37. Escobar C.M., Krajewski S.J., Sandoval-Guzman T., Voytko M.L., Rance N.E. Neuropeptide Y gene expression is increased in the hypothalamus of older women. J Clin Endocrinol Metab 2004, 89:2338-2343.